Total Health | Oncology 📖🔬 retweetledi

If activity is this compelling in wild-type patients, what comes next for Viktoria-1?
Drs. Erica Mayer (@elmayermd) and Wassim Mchayleh discuss the VIKTORIA 1 data and explore how these results could shape expansion strategies and treatment positioning moving forward. Full Discussion --> oncologynexus.com/video/viktoria…
@TotalHealthConf
#VIKTORIA #BreastCancer #HR #HER2
English



















